1. Cardiovascular & Metabolic Disease; Innovative Medicines and Early Development Biotech Unit, AstraZeneca; Mölndal 431 83 Sweden
2. Pharmacometrics Research Group, Department of Pharmaceutical Biosciences; Uppsala University; Sweden
3. Department of Endocrinology; Sahlgrenska University Hospital and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg; Gothenburg Sweden